Zealand Pharma A/S

PINK:ZLDPF USA Biotechnology
Market Cap
$4.36 Billion
Market Cap Rank
#3604 Global
#2348 in USA
Share Price
$61.95
Change (1 day)
-8.90%
52-Week Range
$61.95 - $83.52
All Time High
$141.74
About

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treat… Read more

Zealand Pharma A/S (ZLDPF) - Total Liabilities

Latest total liabilities as of September 2025: $1.63 Billion USD

Based on the latest financial reports, Zealand Pharma A/S (ZLDPF) has total liabilities worth $1.63 Billion USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Zealand Pharma A/S - Total Liabilities Trend (2007–2024)

This chart illustrates how Zealand Pharma A/S's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Zealand Pharma A/S Competitors by Total Liabilities

The table below lists competitors of Zealand Pharma A/S ranked by their total liabilities.

Liability Composition Analysis (2007–2024)

This chart breaks down Zealand Pharma A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.21 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.69 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.62 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zealand Pharma A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zealand Pharma A/S (2007–2024)

The table below shows the annual total liabilities of Zealand Pharma A/S from 2007 to 2024.

Year Total Liabilities Change
2024-12-31 $888.86 Million +129.59%
2023-12-31 $387.15 Million -46.52%
2022-12-31 $723.89 Million -36.49%
2021-12-31 $1.14 Billion +52.48%
2020-12-31 $747.52 Million +109.48%
2019-12-31 $356.84 Million +214.35%
2018-12-31 $113.52 Million -45.63%
2017-12-31 $208.77 Million -49.87%
2016-12-31 $416.43 Million +8.88%
2015-12-31 $382.46 Million +11.20%
2014-12-31 $343.93 Million +1017.67%
2013-12-31 $30.77 Million +2.68%
2012-12-31 $29.97 Million +6.71%
2011-12-31 $28.08 Million -35.35%
2010-12-31 $43.44 Million +68.67%
2009-12-31 $25.75 Million +55.06%
2008-12-31 $16.61 Million -20.92%
2007-12-31 $21.00 Million --